BIOGENESIS BAGO S.A.

Biogenesis Bago S.A. specializes in the manufacturing of biological products, specifically veterinary vaccines and related biologics for livestock health applications. Their technical expertise centers on the development, production, and supply of non-diagnostic biological agents, with demonstrated experience in foot-and-mouth disease (FMD) vaccines and associated veterinary immunobiological formulations. The company operates within the stringent regulatory framework governing biological manufacturing, ensuring product purity, potency, and biosafety in compliance with international veterinary biologics standards. Their specialization in FMD vaccine production indicates advanced capabilities in cell culture, antigen purification, formulation stability, and cold-chain logistics critical for large-scale veterinary use. The contractor maintains a consistent relationship with the U.S. Department of Agriculture, providing critical biological countermeasures for animal disease prevention and agricultural biosecurity. This partnership suggests alignment with USDA’s Animal and Plant Health Inspection Service (APHIS) objectives, particularly in supporting national livestock protection programs through the delivery of high-integrity veterinary biologics. The nature of the awards indicates a trusted role in emergency preparedness and routine prophylactic vaccine deployment for high-value agricultural assets. Biogenesis Bago S.A. is positioned within the biological product manufacturing sector (NAICS 325414), focusing exclusively on veterinary applications rather than human pharmaceuticals. This vertical specialization distinguishes them in the agri-biotech space, serving government-led animal health initiatives that require scalable, GMP-compliant manufacturing of live or inactivated viral vaccines. Their market positioning is that of a niche producer of high-demand veterinary biologics for national livestock defense programs. The company’s organizational structure, certifications, and geographic footprint are not disclosed in available records. While no formal government certifications are listed, their repeated engagement with federal agricultural agencies implies adherence to federal procurement and biological product standards. Their operational presence appears to be globally oriented, supporting international veterinary biosecurity needs through direct government contracts.